MV Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.5K | Sell |
805
-37
| -4% | -$2.96K | 0.01% | 317 |
|
|
2025
Q4 | $80.3K | Sell |
842
-18
| -2% | -$1.76K | 0.01% | 261 |
|
|
2025
Q3 | $84K | Sell |
860
-24
| -3% | -$2.48K | 0.01% | 254 |
|
|
2025
Q2 | $95K | Buy |
884
+53
| +6% | +$5.36K | 0.01% | 246 |
|
|
2025
Q1 | $83.8K | Buy |
831
+7
| +0.8% | +$705 | 0.01% | 255 |
|
|
2024
Q4 | $73.6K | Buy |
824
+6
| +0.7% | +$528 | 0.01% | 259 |
|
|
2024
Q3 | $68.5K | Buy |
818
+4
| +0.5% | +$315 | 0.01% | 270 |
|
|
2024
Q2 | $62.7K | Buy |
814
+96
| +13% | +$7.03K | 0.01% | 270 |
|
|
2024
Q1 | $49.2K | Buy |
718
+13
| +2% | +$836 | 0.01% | 296 |
|
|
2023
Q4 | $40.8K | Buy |
705
+68
| +11% | +$3.63K | 0.01% | 322 |
|
|
2023
Q3 | $33.6K | Buy |
637
+35
| +6% | +$1.84K | ﹤0.01% | 327 |
|
|
2023
Q2 | $32.6K | Buy |
602
+56
| +10% | +$2.92K | ﹤0.01% | 341 |
|
|
2023
Q1 | $27.3K | Buy |
546
+145
| +36% | +$6.83K | ﹤0.01% | 354 |
|
|
2022
Q4 | $18.6K | Buy |
401
+107
| +36% | +$4.63K | ﹤0.01% | 357 |
|
|
2022
Q3 | $11K | Buy |
294
+147
| +100% | +$5.9K | ﹤0.01% | 431 |
|
|
2022
Q2 | $5K | Sell |
147
-329
| -69% | -$13.4K | ﹤0.01% | 549 |
|
|
2022
Q1 | $21K | Buy |
476
+210
| +79% | +$9.1K | ﹤0.01% | 332 |
|
|
2021
Q4 | $11K | Sell |
266
-158
| -37% | -$6.64K | ﹤0.01% | 422 |
|
|
2021
Q3 | $18K | Buy |
424
+208
| +96% | +$9.2K | ﹤0.01% | 324 |
|
|
2021
Q2 | $9K | Buy |
216
+181
| +517% | +$7.62K | ﹤0.01% | 379 |
|
|
2021
Q1 | $1K | Buy |
+35
| New | +$1.32K | ﹤0.01% | 339 |
|
Other funds holding BSX
VCM
VPM
